SEC Form 4 · accession 0001600132-18-000068
Bellerophon Therapeutics, Inc. · BLPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jens Luehring
Director
Period of report
Jun 5, 2018
Accepted (ET)
Jun 7, 2018 · 4:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001600132
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $2.27 | Jun 5, 2018 | A | 38,216 | A | Jun 5, 2019 | Jun 4, 2028 | Common Stock | 38,216 | 58,216 | D |